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ABSTRACT
The influenza A virus genome consists of eight viral
RNAs (vRNAs) that form viral ribonucleoproteins
(vRNPs). Even though evidence supporting segment-
specific packaging of vRNAs is accumulating, the
mechanism ensuring selective packaging of one
copy of each vRNA into the viral particles remains
largely unknown. We used electron tomography to
show that the eight vRNPs emerge from a common
‘transition zone’ located underneath the matrix layer
at the budding tip of the virions, where they appear
to be interconnected and often form a star-like
structure. This zone appears as a platform in 3D
surface rendering and is thick enough to contain
all known packaging signals. In vitro, all vRNA
segments are involved in a single network of inter-
molecular interactions. The regions involved in the
strongest interactions were identified and corres-
pond to known packaging signals. A limited set of
nucleotides in the 50 region of vRNA 7 was shown to
interact with vRNA 6 and to be crucial for packaging
of the former vRNA. Collectively, our findings sup-
port a model in which the eight genomic RNA
segments are selected and packaged as an organ-
ized supramolecular complex held together by
direct base pairing of the packaging signals.
INTRODUCTION
The packaging machinery of RNA viruses must discrim-
inate the genomic viral RNA (vRNA) against a variety of
cellular RNAs, and, most often, other viral RNA species.
Usually, selective packaging of the vRNA is achieved by
the speciﬁc binding of a viral structural protein to a
packaging signal solely present in this RNA. This
general problem reaches an additional level of complexity
in viruses whose genome is segmented, as in the
Orthomyxoviridae family. Among these viruses, Inﬂuenza
A viruses are an important threat for public health (1).
The inﬂuenza A virus genome consists of eight single-
stranded negative-sense RNA segments ranging from
890 to 2341nt that are associated with nucleoprotein
(NP) and a heterotrimeric polymerase complex (2), and ap-
pear as individual ribonucleoprotein complexes (vRNPs)
inside an enveloped ﬁlamentous or spherical structure
(3–7). The eight vRNAs have a common organization: a
long central coding region (in antisense orientation) is
ﬂanked by relatively short segment-speciﬁc untranslated
regions (UTRs) and by two partially complementary
terminal promoters (12nt at the 30-end and 13nt at the
50-end). These are conserved between segments and impose
a panhandle structure to the vRNPs (8,9). As the natural
transmission of inﬂuenza A viruses is initiated at low
multiplicity of infection (m.o.i.), viral particles that do
not incorporate at least one copy of each genomic
segment will fail to replicate (10).
Two models have been proposed for the packaging of
the vRNAs into inﬂuenza A viral particles: a random
model and a segment-speciﬁc model, but growing evidence
supports the existence of a speciﬁc packaging mechanism
(10). First, genetic evidence indicated that inﬂuenza
A virions normally incorporate exactly eight vRNAs
(11–13). Second, electron microscopy of a variety of inﬂu-
enza A virus strains repeatedly showed that seven vRNPs
are organized around a central one (3–5,7). In elongated
and ﬁlamentous viral particles, the vRNPs contact the
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which has been identiﬁed as their budding tips (3,7).
Third, defective interfering RNAs generated from the
vRNA segments revealed the presence of segment-speciﬁc
packaging signals within  100 to  300nt from each end
of the vRNAs [for a review, see Ref. (10)]. Forth, reverse
genetics experiments using segments in which a reporter
gene was substituted for most of the central coding region
pointed to the existence of segment-speciﬁc packaging
signals located in the 30 and 50 terminal regions of every
inﬂuenza A genomic vRNA (14–21). Finally, sequence
analysis showed that the most conserved codons tend to
accumulate in the terminal packaging regions, and point
mutations identiﬁed single nucleotides or short nucleotide
clusters required for optimal packaging of several vRNAs
(5,22,23).
Despite these studies, the molecular basis underlying
segment-speciﬁc packaging of inﬂuenza A vRNAs
remains elusive. Here, we used electron tomography,
native gel electrophoresis and capture of RNA complexes
on magnetic beads to visualize vRNPs inside virions and
analyse the interactions between vRNAs. Collectively, our
ﬁndings support a model in which the eight genomic RNA
segments are selected and packaged as an organized supra-
molecular complex held together by direct base pairing of
the packaging signals.
MATERIALS AND METHODS
Electron tomography
Madin–Darby canine kidney (MDCK) cells were infected
with A/Moscow/10/99 (H3N2) virus at low m.o.i. After
24h, cells and viruses were ﬁxed, stained and embedded
in epon as described (6). Tilt series of uranyl-stained 150–
200nm thick sections were acquired on a Tecnai G2
Sphera electron microscope (FEI Company, Eindhoven,
The Netherlands) operating at 200kV. Digital images
were automatically recorded on a CCD camera (Gatan
Ultrascan 1000) at  25000 nominal magniﬁcation (pixel
size 0.46nm) over a tilt range of  60 to +60 with 1  in-
crements. The images in the tilt series were pre-processed
and aligned with or without gold Educial markers. The
eTomo graphical user interface of the IMOD tomography
package was used to calculate the 3D reconstruction (24).
The Enal tomograms were calculated by weighted
backprojection. Individual virions were extracted from
the calculated tomograms and denoised using an iterative
median ﬁlter (25). The 3D volumes were imported into the
3D visualization software AMIRA (Mercury Computer
Systems, Me ´ rignac, France) for visualization, manual seg-
mentation and surface rendering.
Plasmids and cloning
A/Moscow/10/99 (H3N2) cDNAs were cloned between the
BsmbI sites of pUC2000 vectors starting from the reverse
genetic plasmids (6). These vectors were derived from
pUC19 by introducing a PstI restriction site, remov-
ing the multiple cloning site cassettes and inserting a T7
promoter, the cloning cassette of pHW2000 containing
two BsmbI sites, and a unique restriction site (Eco47III,
Bsh1236I or Ecl136II) between the PstI and EcoRI sites.
In vitro transcription and electrophoretic mobility shift
assay
DNA templates digested with Eco47III, Bsh1236I or
Ecl136II were co-transcribed in vitro for 3h and RNA
complexes were analysed by native agarose gel electro-
phoresis as described (26), except that the samples were
treated with 5U of RNase-free DNaseI (Roche) and that
phenol–chloroform extraction was omitted. Brieﬂy,
linerarized plasmids were incubated in 10ml reactionnal
volume containing 40mM Tris–HCl pH 7.5, 50mM
NaCl, 15mM MgCl2, 1mM spermidine, supplemented
with 5mM DTT, 4mM of each NTP, 1U RNasine
(Promega), 0.05mg/ml BSA, 0.05% Triton X-100 and
0.5ml of home-made T7 RNA polymerase. After 3h of in-
cubation, samples were treated with 5U of RNAse-free
DNase I (Roche) for 1h at 37 C, supplemented with 2ml
loading buffer and loaded on a 0.8% agarose gel contain-
ing 0.01% ethidium bromide. Electrophoresis was per-
formed for 4h at 150V at 4 C in a buffer containing
Tris 100mM, borate 85mM, MgCl2 0.1mM. Gels were
analysed using a Gel Doc (Bio-Rad) imager and the
Quantity One software. The weight fraction (%) of the
RNA mass corresponding to each band in a lane was
determined, and the percentage of intermolecular complex
was determined by dividing the weight fraction of the cor-
responding band by the sum of the weight fractions of all
bands in the lane. Integrity of the RNAs was routinely
checked by denaturing gel electrophoresis.
Nucleoprotein overexpression and puriﬁcation
The expression plasmid coding for NP was a king gift of
Dr Yizhi Jane Tao (Department of Biochemistry and Cell
Biology, Rice University, Houston, USA). Overexpression
and puriﬁcation were performed according to their pub-
lished protocols (27). Brieﬂy, NP was expressed in BL21-
DE3 Escherichia coli cells. After centrifugation, the cell
pellet was resuspended in 50mM Tris–HCl pH 7.5,
300mM NaCl, 5mM b-mercaptoethanol, treated with
lysozyme (1mg/ml) for 30min at 4 C and sonicated.
After treatment with DNAse I (2.5mg/ml) and RNase A
(5mg/ml), and centrifugation (30min at 17000g at 4 C),
NP was recovered from the supernatant by chromatog-
raphy using a Ni-NTA afﬁnity column (Qiagen)
followed by a HiTrap Heparin HP column (Pharmacia)
as described (27). The puriﬁed protein was concentrated
on a centricon 30K (Amicon) device and stored at 4 Ci n
50mM Tris–HCl pH 7.5, 100mM NaCl.
Analysis of vRNA complexes on magnetic beads
Wild-type vRNA 7 and vRNA 7100 50 with a 30 exten-
sion were transcribed in vitro from plasmids linearized
with AatII. After transcription, 20pmol of a 16-mer bio-
tinylated oligonucleotide complementary to the 30 exten-
sion, NP (1 protein/24nt) and NaCl (100mM) were added
to the reaction mixture (20ml ﬁnal volume) and incubated
at 37 C. vRNA 6 was incubated with NP in parallel and
after 30min, the two vRNAs were mixed and incubated
2198 Nucleic Acids Research, 2012,Vol.40, No. 5together for a further 30min at 37 C. M-280 magnetic
beads (Invitrogen, 20ml) were added and the complexes
were allowed to bind for 30min at room temperature.
The beads were washed twice, then treated with 100ml
formaldehyde 95%, EDTA 10mM. After ethanol precipi-
tation, vRNA aliquots were reverse transcribed with
AMV RT (MP Biomedicals) and ampliﬁed by PCR
using Dream-Taq polymerase (Fermentas) and segment-
speciﬁc primers.
Oligonucleotide mapping experiments
Oligodeoxyribonucleotides complementary to vRNA 7
were added to the in vitro transcription reaction (10mM
ﬁnal concentration, including 10000cpm of puriﬁed
50-[
32P]-labelled oligonucleotide). After electrophoresis and
visualization of the RNA species under UV light, gels were
ﬁxed in 10% (v/v) trichloroacetic acid and dried at room
temperature.
Cell culture, reverse genetics, virus growth kinetics and
competition experiments
MDCK cells were purchased from Cambrex Bioscience
(ATCC, CCL34), Walkersville, MD, USA. Cells were
passaged twice weekly in serum free Ultra-MDCK
medium (Cambrex Bioscience) supplemented with 2mM
L-glutamine (Sigma Aldrich, St Louis, MO, USA), peni-
cillin (225U/ml) and streptomycin (225mg/ml) (Cambrex
Bioscience, Walkersville, MD, USA). 293T cells were
maintained in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% foetal calf serum and supple-
mented with 2mM L-glutamine (Sigma Aldrich, St
Louis, MO, USA), penicillin (225U/ml) and streptomycin
(225mg/ml) (Cambrex Bioscience, Walkersville, MD,
USA). All cells were maintained at 37 C with 5% CO2.
Wild-type and mutant A/Moscow/10/99 (H3N2) recom-
binant viruses were produced by reverse genetics as
described earlier (6,28). Brieﬂy, the cDNA corresponding
to the different genes of the wild-type and mutant viruses
were cloned into the pHW2000 vector (28) allowing ex-
pression of both corresponding vRNAs and viral proteins.
Plasmids were mixed with Superfect reagent (Qiagen) in
Opti-MEM (GIBCO-BRL), according to the manufactur-
er’s instructions and added to 293T cells in six-well tissue
culture plates. At 48-h post-transfection, viruses in the
culture supernatant were harvested and used to infect
MDCK cells. After two passages on MDCK cells, titres
were measured using standard methods (6).
In competition experiments, 1mg of wild-type plasmid
and 1mg of the plasmid coding for segment 7 with the
S71–R73 mutation were mixed with Superfect reagent
(Qiagen) in Opti-MEM (GIBCO-BRL) and added to
293T cells. To deﬁne the rate of incorporation of the
mutated vRNP into infectious viral particles, plaque puri-
ﬁcation in MDCK cells was carried out from the super-
natant of the transfected cells. Plaque-puriﬁed viruses
from two independent experiments were analysed by
RT-PCR speciﬁc for the M segment and sequencing.
RESULTS
The 8 vRNPs are interconnected in a transition zone
located underneath the matrix layer at the budding
tip of the inﬂuenza A viral particles
Electron microscopy and tomography previously revealed
the typical ‘7+1’ disposition of the inﬂuenza A vRNPs
within viral particles (3–5,7) and showed that the vRNPs
contact the matrix layer at the budding tip of the
virions (3,7). In some images, pairs of vRNPs appeared
to be locally in close proximity, but whether such contacts
represented speciﬁc interactions with functional signiﬁ-
cance could not be determined (7). Here, we used
electron tomography to visualize the internal organization
of virions of the contemporary human inﬂuenza A/
Moscow/10/99 (H3N2) virus budding from MDCK cells
24-h post-infection. Two large ﬁelds of view revealed 10
and 12 viral particles in which individual vRNPs were
visible as dots (Figure 1A). Eight particles, named
P1–P8, with a low background and distinguishable
vRNPs were selected for detailed analysis (Figure 1B;
Supplementary Figure S1 and Supplementary Movies
S1A and S1B). As previously observed by electron micros-
copy (7), the number of dots gradually increases from
the bottom to the top of the viral particles, up to a
point where the eight individual vRNPs can be distin-
guished (Figure 1B, panels P1-1–P1-5 and P3-1–P3-5,
and Supplementary Movies S1A and S1B). We also
recorded a tomogram providing longitudinal views of a
viral particle still attached to the cell from which it is
budding (Figure 1C). These views show that the vRNPs
contact the matrix layer at the budding tip of the virion, in
agreement with previous electron microscopy data (7). In
the cross sections, between the zone where the eight
vRNPs are individually visible as round dots and the
matrix layer, there is a ‘transition zone’ where the dots
progressively become smaller and elongated. Density pro-
gressively becomes visible between these dots, which ap-
pear to be interconnected, often giving rise to a star-like
structure (Figure 1B, panels P1-6–P1-8 and P3-6–P3-8,
and Supplementary Figure S1). These data strongly
suggest that vRNP/vRNP interactions take place in this
transition zone.
We were able to obtain 3D rendering of the vRNP
surface of particles P1–P4 (Figure 2; Supplementary
Figure S2 and Supplementary Movies S2A and S2B).
In the four particles, eight vRNPs of different length
hang from a common platform that includes the ‘transi-
tion zone’ of the tomograms close to the top of the
viral particles, below the matrix layer, where the vRNPs
appear to be interconnected (Figure 2C). The density of
the tomograms corresponding to the matrix layer, which
is visible all around the viral particles has been omitted
from the 3D surface rendering, but the density between
the ‘transition zone’ and the matrix layer is continuous
(Figure 2C). We systematically measured the thickness
of the platform between adjacent outer vRNPs in P1,
P2 and P3. The platform thickness varied from 5nm
between segments a and b of P2 to 23.1nm between
segments d and e in P1. The mean thickness of the
platform was 13.3±2nm in P1, 13.8±2.1nm in P2
Nucleic Acids Research,2012, Vol.40, No. 5 2199Figure 1. Electron tomography of budding H3N2 inﬂuenza A virions. (A) Two single ﬁelds of view indicating eight virions, named P1–P8, that have
been selected for further analysis. (B) Transversal sections of viral particles P1 (Panels P1-1–P1-8) and P3 (Panels P3-1–P3-8). (C) Longitudinal
sections of a viral particle attached to the cell from which it is budding.
2200 Nucleic Acids Research, 2012,Vol.40, No. 5and 17.5±0.8nm in P3. The platform of P4 was thicker
(up to 30nm), and this was likely the consequence of a
lower signal over noise ratio for this particle. We thus
omitted this particle when comparing the thickness
(averaged over P1, P2 and P3) of the platform between
successive vRNPs: it ranged from 9.9±1.9nm between
segments f and g to 20.0±1.6nm between segments
d and e. Importantly, in general, no contact between
Figure 2. 3D surface rendering of the vRNPs in budding H3N2 inﬂuenza A virions. (A and B). Side and bottom views of the 3D surfaces of the
interior of particles P2 (A) and P3 (B). vRNPs are labelled anticlockwise from a to g, starting with the two longest adjacent vRNPs, and h is the
central vRNP. (C) Views of the top of P2 without (upper panel) or with superimposition of the 3D surfaces. (D) Correlation between the length of
the vRNPs and the length of the vRNAs. The length of the vRNPs measured in the 3D-reconstructions of P2 (blue dots) and P3 (red squares) is
plotted against the length of the vRNAs. The compaction factor of the vRNAs in the vRNP is calculated from the slope of the lines
(slope=0.032±0.004 for P2 and 0.032±0.003 for P3).
Nucleic Acids Research,2012, Vol.40, No. 5 2201vRNPs was observed outside the platform. The only ex-
ception was observed in particle P3, in which the tip of
vRNP d and the middle of vRNP e are in close proximity
(Figure 1C and Supplementary Figure S2B). As this
contact was not reproducibly observed, its signiﬁcance,
if any, is unclear.
Within the virions, vRNPs adopt the hairpin conform-
ation previously observed at high resolution for an artiﬁ-
cial mini-vRNP (8,9), and the ‘transition zone’ most likely
contains the polymerase complex associated with the ends
of each vRNA, as well as the terminal regions of these
RNAs. To determine the compaction factor of the
vRNPs in particles P2 and P3, we plotted the length of
the vRNPs determined from the 3D-reconstructions as a
function of the known length of the vRNAs (Figure 2D).
The mean compaction value derived from the slope of the
lines is 31–32nt/nm. Taking this compaction factor into
account, our data indicate that the platform of virions P1,
P2 and P3 can incorporate a mean value of 206–271nt,
ranging from 153nt between segments f and g to 310nt
between segments d and e.
In vitro, the packaging signals mediate interactions
between the viral RNA segments
It has been proposed that the packaging signals might be
involved in intermolecular base pairing (16). As identiﬁca-
tion of intermolecular interactions between vRNAs using
virology approaches has not been successful yet, we tried
to identify such interactions using an in vitro approach.
We cloned the segments of the human inﬂuenza A/
Moscow/10/99 (H3N2) virus under the control of a T7
promoter, and we co-transcribed all possible RNA pairs
in vitro and analysed the RNA/RNA interactions by
native gel electrophoresis (Figure 3 and Supplementary
Figure S3). Even though some vRNAs formed low
amounts of homodimers when transcribed alone, these
complexes almost completely disappeared to the expense
of intermolecular complexes in the co-transcription experi-
ments. Each vRNA formed clearly visible complexes with
at least one other RNA segment. In most cases, the band
corresponding to the complex was easily identiﬁed owing
to its migration relative to the monomeric and homo-
dimeric bands and to the fact that it was only present
Figure 3. In vitro interactions between vRNAs. (A) Analysis of the RNA/RNA interactions by native agarose gel electrophoresis. Individual vRNAs
are indicated by arrows and intermolecular complexes are marked by asterisks. (B) Quantiﬁcation of the complexes. The weight fraction (%) of the
RNA mass migrating as an intermolecular complex is expressed as mean±SEM (n=3 19).  , <10% complex. The grey levels (on a 0–100 scale)
directly correspond to the percentage of complex formed.
2202 Nucleic Acids Research, 2012,Vol.40, No. 5when two vRNAs were co-transcribed (Figure 3A). Only
in the cases of vRNAs with similar lengths, were we
unable to discriminate between the heterodimeric complex
and homodimers (Supplementary Figure S3). However, in
these cases, when both vRNAs were co-transcribed, the
percentage of homo/heterodimer was lower that the
added percentages of homodimers when each vRNAs
were transcribed individually, suggesting these vRNA
pairs did not interact (Supplementary Figure S3). Out of
28 possible intermolecular interactions, 8 were reprodu-
cibly detected, while the remaining ones were weak or un-
detectable (Figure 3 and Supplementary Figure S3). Not
all interactions have the same stability, as the RNA mass
engaged in intermolecular complexes ranged from 15% to
54% (Figure 3). Noticeably, the eight strongest inter-
actions are sufﬁcient to interconnect all vRNA segments
in a single interaction network.
To test whether this network might be relevant to the
selective packaging of the vRNPs, we analysed the effect
of deletions in the terminal regions of the vRNAs, where
the segment-speciﬁc packaging signals are located
(5,15,16,19,22,23), on the three strongest interactions de-
tected in our assay, namely the interactions between
vRNAs 6 and 7, 4 and 8, and 4 and 7 (Figure 3B).
Deleting 100nt in the 50 region of vRNA 6 reduced the
interaction with vRNA 7 by 2.5-fold (Figure 4A and B).
Similarly, this interaction was reduced 10-fold by a 100nt
deletion in the 50 region of vRNA 7 (Figure 4B). On the
other hand deletions in the 30 region of either vRNA 6 or
vRNA 7 had no signiﬁcant effect on the interaction be-
tween these vRNAs. Concerning the interaction between
vRNAs 4 and 8, deleting 97 or 100nt at the 50-end of the
coding region of vRNA 4 or 8 reduced complex formation
by 2- and 2.5-fold, respectively, whereas deletions at the
30-end of the coding regions of vRNA 4 or 8 did not
impair this interaction (Figure 4A and C). A somewhat dif-
ferent picture was observed with the interaction between
vRNAs 4 and 7 (Figure 4A and D). Deletions in the 30 and
50 regions of vRNA 7 both impacted this interaction, even
though the deletion in the 30 region had a more dramatic
effect (4-fold, versus a 35% reduction). On the contrary,
deletions at the 30 or the 50-end of the coding region of
vRNA 4 had no signiﬁcant impact on this interaction. It is
possible that the region(s) of vRNA 4 interacting with
vRNA 7 is (are) located either in the UTRs or in a more
central part of the coding region. However, we cannot
exclude the existence of stable redundant interactions
involving both terminal domains of the coding region of
vRNA 4.
To corroborate the idea that packaging signals mediate
interactions between vRNPs via direct vRNA-vRNA
interaction, we next focused on vRNA 7 and its inter-
action with vRNA 6. The analysis of the RNA complexes
formed in vitro described above did not allow the study of
the intermolecular interactions taking place in the presence
of NP: this protein inhibited in vitro transcription, and if
using puriﬁed vRNAs, the vRNA/NP complexes could
not be resolved on agarose gels due to aggregation (data
not shown). We therefore developed an alternative proto-
col in which a modiﬁed vRNA 7 without or with a 100nt
deletion at the 50-end of the coding sequence was modiﬁed
Figure 4. Effect of terminal deletions on the three strongest in vitro
vRNA/vRNA interactions. (A) Schematic representation and nomen-
clature of the wild-type and mutant vRNAs. Deletions are represented
by grey rectangles. Numbering of the genomic vRNAs is from 30-t o
50-end. (B–D) Representative gels and quantiﬁcations are shown for
interactions between wild-type or mutant vRNAs 6 and 7 (B), 4 and
8 (C) and 4 and 7 (D). Intermolecular complexes are marked by
asterisks. The weight fraction (%) of the RNA mass migrating as an
intermolecular complex was determined for each vRNA pair, and for
each panel the intermolecular complex obtained with mutant vRNAs
was normalized relative to the complex formed by the two wild-type
vRNAs. Quantiﬁcations are expressed as mean±SEM (n=3 10).
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DNA oligonucleotide. Modiﬁed vRNA 7 and vRNA 6
were ﬁrst transcribed and incubated separately with
saturating amounts of NP. They were then incubated
together, and the NP-covered vRNA 7 and vRNA 7/
vRNA 6 complexes were retained on streptavidin-coated
beads. Finally, vRNAs retained on the beads were detected
by segment-speciﬁc RT-PCR. Even though some back-
ground binding of vRNA 7 and vRNA 7100 50 to the
beads was detected when the biotinylated DNA oligo-
nucleotide was omitted, the PCR signal was stronger when
it was included in the reaction mixture (Figure 5A).
Binding of vRNA 6 to the beads was detected in the pres-
ence of vRNA 7, but not in its absence or in the presence
vRNA 7100 50 (Figure 5B) in agreement with the analysis
by native gel electrophoresis (Figure 4B). Importantly,
similar results were observed with ‘naked’ vRNAs and
NP-covered RNAs (Figure 5), indicating that NP does
not prevent the interaction between vRNPs 6 and 7 and
that it does not affect its speciﬁcity.
A short sequence of vRNA 7 interacts with vRNA 6 and
modulates packaging of vRNA 7
Next, we used the native gel electrophoresis assay to map
the region of vRNA 7 interacting with vRNA 6 more
precisely by including a series of DNA oligonucleotides
complementary to the former vRNA during in vitro tran-
scription (Figure 6A). All oligonucleotides except M5
bound vRNA 7 to some degree under the conditions of
in vitro transcription, suggesting that the M5 target se-
quence is involved in a stable intramolecular structure.
Oligonucleotides M1–M7, which bind to the 30 region of
vRNA 7, did not signiﬁcantly inhibit the interaction with
vRNA 6. One of them even increased complex formation
(Figure 6A), suggesting that interactions might take
place between the 50 and 30 regions of vRNA 7, and that
binding of an oligonucleotide to the 30 region might facili-
tate intermolecular interactions involving the 50 region.
Most oligonucleotides binding to the 50 region of vRNA
7 also had limited effects, except M8, which reduced for-
mation of the vRNA 6/vRNA 7 complex by 4-fold (Figure
6A). M8 was hardly detected in the complex, further
demonstrating that nucleotides 918–940 of vRNA 7
played a central role in the interaction with vRNA 6.
Accordingly, deleting the corresponding sequence in
vRNA 7 decreased complex formation by 4-fold (Figure
6B, mutant 7918–940). Noticeably, this region
encompasses the highly conserved codons S71 and R73
of protein M2 that affect inﬂuenza A/PR/8/34 virus
growth, virion assembly and genome packaging (5).
Importantly, when introduced in our in vitro system, mu-
tations S71–R73 (i.e. substitution of nucleotides 924, 925,
926, 930 and 932) produced a 2-fold reduction of the
complex formed between vRNAs 6 and 7 (Figure 6B).
Thus, our results show that both codons S71 and R73
and the ﬂanking nucleotides of segment 7 are important
for the interaction with vRNA 6.
As the importance of codons S71 and R73 in genome
packaging has only been demonstrated for a laboratory
adapted strain of H1N1 inﬂuenza A virus (5), we intro-
duced the same silent mutations in recombinant
A/Moscow/10/99 (H3N2), which is a strain that recently
circulated in the human population. As compared to the
wild-type virus, mutant H3N2 virus produced 5- to 10-fold
less infectious virions (Figure 7A). We checked that S71–
R73 mutations have no effect on vRNA synthesis or viral
gene expression 8-h post-infection (data not shown).
Expression of proteins M1 and M2 was analysed by
Western blot using mouse monoclonal antibodies after
infection at a m.o.i. of 4. To prove that they affect packag-
ing of vRNA 7, we produced recombinant viruses from
293T cells transfected with equimolar amounts of the eight
wild-type reverse genetics cDNA clones plus the reverse
genetic cDNA clone of segment 7 containing the S71–R73
mutation (Figure 7B). This set-up allows competition
between wild-type and mutant vRNA 7 for incorporation
into viral particles. To determine the incorporation rate of
the mutated segment 7 vRNPs into infectious viral par-
ticles, plaque puriﬁcation was carried out from the super-
natant of the transfected cells. A total of 72 randomly
chosen plaque-puriﬁed viruses were analysed by
Figure 5. Interaction of wild-type vRNA 7 and vRNA 7100 50 with
vRNA 6 in the presence of NP. vRNA 7 without or with a 100nt
deletion at the 50-end of the coding sequence was modiﬁed to include
a3 0 overhang complementary to a biotinylated DNA oligonucleotide.
Modiﬁed vRNA 7 and vRNA 6 were ﬁrst transcribed and incubated
separately with saturating amounts of NP, then incubated together. The
biotinylated DNA oligonucleotide was used to retain the complexes on
magnetic beads, and segment-speciﬁc PCR was used to detect vRNA 7
(A) and vRNA 6 (B) retained on the beads in the absence ( NP) or in
the presence of NP (+NP).
2204 Nucleic Acids Research, 2012,Vol.40, No. 5sequencing: all incorporated wild-type segment 7,
demonstrating that codons S71 and R73 have a major
impact on the selective incorporation of segment 7
(Figure 7B).
A model for the internal organization of human
H3N2 inﬂuenza A virions
As our results suggest that the intermolecular vRNAs
interactions we detected in vitro are relevant to vRNP
packaging, we combined these data with our tomography
data to analyse the relative disposition of vRNPs within
human H3N2 inﬂuenza virions (Figure 8). According to
Figure 2D, it is possible to discriminate vRNAs 1, 2 and
3 from the other vRNAs, based on the length of the
vRNPs, but not between them. Similarly, it is possible
to discriminate vRNAs 4 and 5, on one hand, and
vRNAs 6–8 (for P2) or 6 and 7 (for P3), on the other
hand, from the other vRNAs. In all four 3D reconstruc-
tions, two of the three longest vRNPs are contiguous and
were used as starting points for anticlockwise labelling
of the vRNPs, while the third one is opposite to them
(Figure 2; Supplementary Figure S2 and Supplementary
Movies S1A, S1B, S2A and S2B). Even though there
Figure 6. Precise mapping of a region of vRNA 7 interacting with vRNA 6. (A) A region interacting with vRNA 6 was identiﬁed using oligo-
nucleotides complementary to the 30 and 50 regions of vRNA 7. A representative gel is shown. Ethidium bromide (EtBr) staining allowed quanti-
ﬁcation of the complex formed between vRNAs 6 and 7, while autoradiography of the
32P radiolabelled oligonucleotides allowed to monitor binding
of the DNA oligonucleotides to vRNA 7 during in vitro transcription. (B) A deletion or substitutions in the 918–940 region of vRNA 7 affect
interaction with vRNA 6. Mutation S71–R73 correspond to substitution of nucleotides 924, 925926, 930 and 932. In A and B, intermolecular
complexes are marked by asterisks. Relative variations of the amount of complex were determined as in Figure 4 and are given as mean±SEM
(n=3 7).
Nucleic Acids Research,2012, Vol.40, No. 5 2205is little difference between the length of the fourth and
ﬁfth vRNPs, the fourth one was always the central one,
strongly suggesting that vRNP h contains vRNA 4
(Figure 1B, panels P1-1, P1-2 and P3-2; Figure 2A–D;
Supplementary Figure S2 and Supplementary Movies
S1A, S1B, S2A and S2B). The central location of vRNA
4 ﬁts with the observation that this vRNA interacts with
three different partners in vitro, whereas vRNA 5 has only
one partner (Figures 3, 8B and D). This in turn allows
identiﬁcation of vRNA 5 in the 3D reconstructions of
P2 and P3. In P3, vRNA 8 can be identiﬁed as the
shortest vRNP (Figures 2B, C and 8C), and it is located
next to vRNA 5 in agreement with the in vitro interaction
data (Figures 3 and 8D). Noticeably, the tomography data
indicate that all inﬂuenza A H3N2 virions do not share the
same internal organization, as vRNA 5 has different loca-
tions in P2 and P3 (Figure 8A and C). Note that the inter-
action network deﬁnes a block of four external vRNPs
comprising vRNAs 1, 7, 6 and 2 or 3, but that the orien-
tation of this block can be deduced neither from tomog-
raphy nor from the in vitro interaction network.
Nevertheless, by combining the tomography data with
the in vitro interaction network, and assuming that, in
virions, interactions preferentially take place between
close neighbours, the number of possible arrangements
of the vRNPs in P2 and P3 is reduced from 5760 to 4
(Figure 8C and D). As there are two vRNAs that are
each involved in three intermolecular interactions while
not interacting together (vRNAs 4 and 6), there will
always be at least one interaction linking non-adjacent
vRNAs, and we selected arrangements with exactly one
such interaction (Figure 8C and D). Measuring the
length of the vRNPs in P4 was difﬁcult, as their upper
end could not always be identiﬁed precisely. However,
our data suggest that the internal organization of the
vRNAs in P1 and P4 is similar to P3.
DISCUSSION
Increasing evidence supports the notion that the eight
vRNAs constituting the inﬂuenza A genome are speciﬁc-
ally packaged into virions, but despite numerous efforts,
the molecular mechanism underlying this process remains
largely unknown (10). Some virology data (5,19,23,29)
suggested the existence of a ‘viral genome complex’ that
might involve direct or indirect interactions between
vRNAs, but no direct evidence was provided.
Our electron tomography data (Figures 1 and 2;
Supplementary Figures S1 and S2 and Supplementary
Movies S1A, S1B, S2A and S2B) revealed that in
budding viral particles, there is a transition zone
between the matrix layer at the budding tip of the
virions and the region where the eight vRNPs adopt the
classical ‘7+1’ arrangement. In this zone, which appears
as a platform in the 3D surface rendering, the dots corres-
ponding to the vRNPs progressively become elongated
and interconnected in a star-like structure. The common
platform from which the 8 vRNPs emerge can accommo-
date a mean value of 206–271nt, ranging from 153nt
between segments f and g to 310nt between segments d
and e. Thus, the platform is thick enough to accommodate
all previously deﬁned packaging signals, which are usually
located within 100nt or less of the vRNA ends (14–23)
(Figure 2). In most particles, no close contact between
vRNPs was observed outside this platform, suggesting
that speciﬁc interactions between vRNPs, which are a pre-
requisite for speciﬁc packaging, take place within the
platform. This idea is supported by the connections
observed between the vRNPs in the transition zone of
the tomograms. We suggest that the supramolecular
complex depicted in Figure 2, Supplementary Figure S1
and Supplementary Movies S2A and S2B is a key inter-
mediate in the selective packaging of inﬂuenza A vRNPs.
Several groups reported that the typical ‘7+1’ arrange-
ment of the vRNPs is more frequently observed in
budding virions than in puriﬁed viral particles (4,7). In
keeping with these observations, we have been unable to
obtain a clear view of the interior of puriﬁed viruses,
Figure 7. Effect of silent mutations S71 and R73 on viral replication
and on incorporation of vRNA 7. (A) MDCK cells were infected at a
m.o.i. of 10
 4 with wild-type recombinant A/Moscow/10/99 (H3N2)
virus or a virus bearing silent mutations at M2 codons 71 and 73.
The release of viral progeny into the supernatant was monitored
by determining the tissue culture infective dose (TCID50). Points cor-
respond to the mean of two experiments; the data ranges are smaller
than the symbol size. (B) Strategy and output of the competition
experiment.
2206 Nucleic Acids Research, 2012,Vol.40, No. 5suggesting that the vRNP complex might disorganize or
dissociate after budding.
Comparison of four individual viral particles showed
that while distribution of the four longest vRNPs seems
to be conserved amongst virions, the disposition of the
shorter vRNPs is not absolutely conserved (Figures 2
and 8). The limited variability existing in the relative dis-
position of vRNPs between virions does not contradict the
existence of segment-speciﬁc intermolecular interactions,
but implies some ﬂexibility of the vRNPs.
Selective packaging of the eight vRNAs in inﬂuenza A
virions require a minimum of seven intersegment inter-
actions. In principle, these interactions could be
mediated by direct base pairing between the vRNAs, or
by RNA binding proteins. As not a single cellular or viral
protein able to selectively recognize a packaging signal of
inﬂuenza A virus vRNAs has been identiﬁed to date (10),
direct RNA interactions are our favourite hypothesis. A
similar, albeit more simple, example is found in retro-
viruses, which package their genome as RNA homodimers
(30). Here, we tested the existence of intermolecular
vRNA interactions in vitro, following an approach that
allowed the identiﬁcation of the dimer linkage sequences
of many retroviral RNAs (30,31).
In vitro, each vRNA establishes at least one intermo-
lecular interaction and the eight vRNAs are involved in a
single interaction network (Figure 3). Currently, we
cannot ascertain that all interactions observed in vitro
take place in vivo, and that, conversely, all inter-vRNA
interactions potentially taking place in vivo can be ob-
served in our system. We analysed the interactions at
37 C in a buffer containing 90mM monovalent cations,
15mM Mg
2+ and 1mM spermidine. Under the in vitro
transcription conditions,  6mM Mg
2+ ions are bound
to the NTPs. Hence, the ionic and temperature conditions
of our assay do not dramatically differ from those sup-
posed to prevail in vivo. Moreover, the fact that the
regions involved in the three strongest inter-vRNAs inter-
actions in vitro correspond to known packaging regions
(Figure 4), even when they could be narrowed down to
a few nucleotides (Figure 6), strongly argues in favour of
the relevance of our ﬁndings for the segment-speciﬁc
mechanism of incorporation of the vRNPs in inﬂuenza
A virions.
Surprisingly, two of the interactions we analysed
involve vRNA pairs that have a globally parallel orien-
tation (they involve the 50 region of both vRNAs). This
does not preclude that locally the two vRNAs might adopt
an anti-parallel orientation and interact via clas-
sical base pairing (Supplementary Figure S4). An analo-
gous situation exists in retroviruses. EM pictures
revealed a globally parallel orientation of the two copies
of genomic RNA molecules, and such an orienta-
tion likely exists in virions to allow efﬁciency recombin-
ation. However, it is now known that this globally parallel
orientation is maintained by locally anti-parallel inter-
actions (30,31).
In the case of vRNA 7, we showed that a limited set of
nucleotides (mutations S71–R73) is important for inter-
action with vRNA 6 (Figure 6). Mutations S71–R73
reduced replication of our contemporary H3N2 circulating
strain by 5- to 10-fold (Figure 7A), in agreement with
previous results obtained with a H1N1 laboratory strain
(5). In addition, our competition experiment indicated
Figure 8. Possible arrangements of the vRNPs within budding H3N2 inﬂuenza A virions. Top views of the possible arrangements of the vRNPs in P2
(A and B) and P3 (C and D) based on tomography data alone (a and c) or incorporating the in vitro interaction data (B and D). The intermolecular
RNA interactions identiﬁed in vitro are indicated by thick grey line. The two thin lines correspond to the interaction between vRNAs 3 and 4 and are
mutually exclusive, depending on the actual location of vRNAs 2 and 3.
Nucleic Acids Research,2012, Vol.40, No. 5 2207that this mutation has a strong negative impact on the
selective incorporation of vRNA7 (Figure 7B).
Globally, terminal deletions revealed that regions con-
taining the previously identiﬁed packaging signals play a
crucial role in the vRNA/vRNA interactions we detected
in vitro. Interestingly, the 50 and 30 regions of vRNA 7 are
involved in interactions with different vRNA partners, an
observation that ﬁts with the fact that both terminal
regions of the coding sequences are required for optimal
packaging of the inﬂuenza A vRNAs (14,16,17,19–23).
Note that none of the mutations that reduced intermolecu-
lar RNA interactions abolished them completely, suggest-
ing a certain level of redundancy. Similarly, most deletions
have rather limited effects on vRNA packaging (14–21).
A technical limitation of the in vitro analysis resides in
the analysis of the RNA interactions in the presence of
NP. Our data obtained using this protein shows that it
does not affect the speciﬁcity of the interaction between
vRNAs 6 and 7 (Figure 5). Unfortunately, unspeciﬁc
binding of some vRNAs to the magnetic beads hindered
generalization of this assay (Figure 5 and data not shown).
Crystal structures of NP suggested that RNA binds at the
surface of the protein oligomers (27,32), and chemical
probing indicated that NP increases the accessibility of
the vRNA bases (33). Thus, NP might facilitate intermo-
lecular interactions between vRNAs, rather than prevent
them. The presence of stable intramolecular RNA struc-
tures within vRNPs is unclear. A previous study with
puriﬁed vRNP 8 indicated that the 50 region of this
vRNA is accessible to single-strand speciﬁc probes,
except for the terminal promoter (34). However, vRNPs
are susceptible to RNase V1, a clear indication of the ex-
istence of base paired regions (35).
Our in vitro approach opens up the possibility to
identify the intermolecular interactions between inﬂuenza
A vRNAs at the nucleotide level. This would in turn allow
testing of the functional role of these interactions by intro-
ducing point mutations in the interacting sequences. This
work is in progress in our laboratory but is complicated by
several factors. First, the bioinformatics approach is of
limited use as the number of possible interactions is
huge, even when deletion mutants have identiﬁed the
region of the vRNAs that are involved. Second, the oligo-
nucleotide mapping strategy we used to identify a short
region of vRNA 7 interacting with vRNA 6 does not
always work because some oligonucleotides do not anneal
to their target in the condition of the in vitro assay. Third,
as discussed above, some interactions seem to be at least
partially redundant, masking the effects of deletions.
Our combined structural and biochemical approaches
strongly favour a model in which the eight genomic
vRNAs are selected and packaged as an organized supra-
molecular complex held together by base pairing between
previously identiﬁed packaging regions. As packaging of
orthologous vRNAs is a prerequisite for genetic reassort-
ment of inﬂuenza viruses, our ﬁndings also suggest that
interactions between heterologous vRNAs is crucial for
this process (36). Conservation of the sequences involved
in the inter-vRNA interactions is likely to be a key factor
in the emergence of reassortant viruses, which can
generate pandemic viruses.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online:
Supplementary Figure 1–4; Supplementary Movies 1A,
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